Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.
Lonza signs agreement to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds, for an enterprise value of $3 billion (CHF 2.3 billion).
Forma Life Sciences launches as US-based contract development and manufacturing organization (CDMO) for oral solid dosage development and commercial manufacturing in Irvine, California.
Early CMC decisions determine success. Learn how structured planning and enabling technologies accelerate small-molecule programs to the clinic.
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability.
Asahi Kasei will acquire all shares in the German biopharmaceutical company Aicuris Anti-infective Cures for approximately €780 million.
Investment marks continued progress against AbbVie's $100 billion commitment to US R&D and capital investments, including manufacturing, over the next decade.
DFE Pharma announces the launch of its continuous manufacturing (CM) platform. It is designed to support pharmaceutical companies in the development, optimization, and lifecycle management of CM processes.
Axplora announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans site and appointed François Houbart as Head of Site.
Alkermes has finalized its acquisition of Avadel Pharmaceuticals, bolstering its presence in the sleep medicine market.
Belén Garijo to become Chief Executive Officer of Sanofi.
AsymBio, a subsidiary of Asymchem Group, has established integrated technology platforms including cell line development, upstream/downstream processing, conjugation toolbox, and analytics.
Fujifilm Biotechnologies expanded manufacturing and process development presence in the North East of England to support vital biomanufacturing of innovative medicines and vaccines in the United Kingdom.
Veit Bergendahl will assume operational responsibility for process development, clinical and commercial cGMP manufacturing, engineering and technology as well as automation in production from April 1, 2026.
Sanofi has completed its acquisition of Dynavax, adding its adult vaccines and pipeline candidates to strengthen Sanofi’s presence in adult immunization.
WuXi Biologics partners with Sinorda on bispecific antibodies for autoimmune diseases and HanchorBio on fusion proteins for oncology and immunology.
Siegfried signed binding agreements to acquire three drug substance sites in the US and Australia.
Accelerating API Excellence: Innovation, Quality, and Compliance in Pharmaceutical Manufacturing
Tjoapack is expanding its oral solid dose (OSD) bottle packaging capabilities at its Etten-Leur, Netherlands, facility, enhancing flexibility, efficiency, and GMP-compliant packaging options to meet growing demand.
Company announces two new additional manufacturing facilities to be built in North Carolina and Pennsylvania; continues to deliver on $55 billion US investment.
AbbVie will acquire West Pharmaceutical Services’ Tempe, Arizona, manufacturing facility for over $175 million to expand US drug delivery device capacity, with closing expected mid-2026.
Sharp Sterile Manufacturing announced a $28 million expansion of its Lee, Massachusetts site to boost pharmaceutical production capacity and create high-skilled life sciences jobs.
This infographic hopes to provide scientists with a comprehensive overview of fluorescence imaging strategies for extracellular vesicle research.
How CDMOs are navigating uncertainty, forging partnerships, and embracing flexibility.
Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D.
Halozyme has acquired Elektrofi to expand its drug delivery portfolio, with royalty revenues expected to start by 2030 as partnered products advance to clinical development.
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
AGC Biologics has partnered with Rarity PBC to provide development and GMP manufacturing of a gene therapy aimed at treating a rare, life-threatening immune disorder.
Johnson & Johnson is acquiring clinical-stage biotech Halda Therapeutics for $3.05 billion to enhance its oncology pipeline.
Novartis plans to establish a flagship manufacturing hub in North Carolina by 2027-2028 as part of a $23 billion investment in US infrastructure.
This infographic provides industry professionals and senior scientists with insights into detailed methodologies for addressing stability challenges in protein therapeutics.
Europe-wide contract logistics for pharmaceuticals and healthcare - Loxxess and Michael Kuhn each bring 25 years of experience to the table - what does that mean?
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
Hovione has completed a $100 million investment to double spray-drying capacity and expand its East Windsor, New Jersey site, positioning the facility to meet growing US demand.
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
